CLOSE X

ERIS LIFESCIENCES LTD.

NSE : ERISBSE : 540596ISIN CODE : INE406M01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE1790.2568.75 (+3.99 %)
PREV CLOSE ( ) 1721.50
OPEN PRICE ( ) 1715.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 135467
TODAY'S LOW / HIGH ( )1715.00 1909.55
52 WK LOW / HIGH ( )988.95 1727.5
NSE1791.1075.8 (+4.42 %)
PREV CLOSE( ) 1715.30
OPEN PRICE ( ) 1715.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1791.10 (166)
VOLUME 3104233
TODAY'S LOW / HIGH( ) 1715.60 1910.00
52 WK LOW / HIGH ( )987.1 1725
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 25-01 2007
Management Info
Amit Indubhushan Bakshi - Chairman Amit Indubhushan Bakshi - Managing Director
Registered Office

Address Shivarth Ambit, Plot No. 142/2,Ramdas Road, Off S B R,Near Swati Bungalows, Bodakdev,
Ahmedabad,
Gujarat-380054

Phone 079 30451000 / 1001

Email eris@erislifesciences.com

Website www.eris.co.in

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
19May Eris Lifesciences informs about invest
Pursuant to the requirement of Regulation 30 of SEBI (Listing Obligation..
13May Eris Lifesciences informs about board
Eris Lifesciences has informed that a Meeting of the Board of Directors..
13May Eris Lifesciences submits analyst meet
In accordance with the applicable requirements and regulations of the Se..
13May Eris Lifesciences informs about invest
Further to letter dated May 13, 2025, intimating about the date of the B..
21Mar Eris Lifesciences Informs about clarif
With refer to email bearing ref no. L/SURV/ONL/PV/ARJ/ 2024-2025/381 dat..
Financials
in Millions
QTR Mar 25 ANNUAL 25
Net Profit304.7773.9
Gross Profit 411.8 1200.5
Operating Profit 1377.25220.6
Net Sales 4047.716977.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
up  10178.55 (1.97%)
M.Cap ( in Cr)25446.38
Pfizer (BSE)
up  5889.00 (1.98%)
M.Cap ( in Cr)26940.84
Ajanta Pharma (BSE)
up  2728.75 (3.07%)
M.Cap ( in Cr)34085.39
Innova Captab (BSE)
up  954.00 (9.24%)
M.Cap ( in Cr)5459.26
Fredun Pharma (BSE)
up  801.00 (8.19%)
M.Cap ( in Cr)378.21
Shareholding Pattern
PROMOTERS 54.85%
NON-INSTITUTION 18.66%
MUTUAL FUNDS/UTI 16.59%
FI/BANKS/INSURANCE 0.69%
GOVERNMENT 0%
FII 0%
Mf Holdings
Scheme NameHold(%)
HDFC Pharma and Healthcare Fund-Reg(G)3.31
Quantum Small Cap Fund-Reg(G)3.21
Bank of India Consumption Fund-Reg(G)3.00
UTI Healthcare Fund-Reg(IDCW)2.90
HDFC Small Cap Fund-Reg(G)2.80
Bank of India Mfg & Infra Fund-Reg(G)2.73
Bank of India Multi Cap Fund-Reg(G)2.43
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors